CLX
Clorox Company (The) · Consumer Defensive · Household & Personal Products
TECHSellZACKSHold
R500#344 today
$80.41
-0.30% today · -4.05% 1W
Oct 2 close or latest
PreviewWhy it's moving
Reddit attention is surging
- CLX −0.30% on the last session vs SPY +0.74%: −1.0 pts of stock-specific move.
- Aftermath, big drop (Sep 28): After its 74 big drops in the past 5 years, CLX typically gained 0.2% over the next day (median) and was higher 59% of the time; half the outcomes fell between -0.9% and +0.8%. An ordinary day: +0.0%. Among S&P 500 stocks after big drops, that ranks #42 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Nov 3
In 30 days
EPS estimate
$1.09
$0.81 to $1.20 · 15 analysts
Revenue estimate
$1.9B
$1.9B to $1.9B
Track record
6/8 beats
last 8 reports · moved ±4.1% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 AMC | 4Q2026 | $1.65 | $1.66 | +$0.01 (+0.9%) beat | $1.9B | +6.5% +4.7 vs SPY | -0.2% | +9.6% |
| Apr 30, 2026 AMC | 3Q2026 | $1.54 | $1.64 | +$0.10 (+6.2%) beat | $1.7B | -9.7% -9.9 vs SPY | -5.7% | -4.5% |
| Feb 3, 2026 AMC | 2Q2026 | $1.43 | $1.39 | −$0.04 (−3.0%) miss | $1.7B | +2.4% +2.9 vs SPY | -1.0% | +5.6% |
| Nov 3, 2025 AMC | 1Q2026 | $0.78 | $0.85 | +$0.07 (+9.2%) beat | $1.4B | +1.2% +2.4 vs SPY | +2.2% | -4.1% |
| Jul 31, 2025 AMC | $2.21 | $2.87 | +$0.66 (+29.9%) beat | — | -2.0% -0.3 vs SPY | +1.4% | +0.4% | |
| May 5, 2025 AMC | $1.56 | $1.45 | −$0.11 (−7.1%) miss | — | -2.4% -1.6 vs SPY | -3.2% | -0.2% | |
| Feb 3, 2025 AMC | $1.40 | $1.55 | +$0.15 (+10.7%) beat | — | -7.2% -7.9 vs SPY | -3.6% | -7.9% | |
| Oct 30, 2024 AMC | $1.39 | $1.86 | +$0.47 (+33.8%) beat | — | +1.3% +3.3 vs SPY | +3.4% | +4.0% | |
| Aug 1, 2024 AMC | $1.55 | $1.82 | +$0.27 (+17.4%) beat | — | +7.4% +9.3 vs SPY | +5.9% | +7.6% | |
| Apr 30, 2024 AMC | $1.37 | $1.71 | +$0.34 (+24.8%) beat | — | -5.6% -5.2 vs SPY | -5.4% | -4.5% | |
| Feb 1, 2024 AMC | $1.10 | $2.16 | +$1.06 (+96.4%) beat | — | +5.6% +4.6 vs SPY | +7.1% | +4.2% | |
| Nov 1, 2023 AMC | −$0.23 | $0.49 | +$0.72 (>+100%) beat | — | +6.6% +4.7 vs SPY | +10.5% | +14.3% | |
| Aug 2, 2023 AMC | $1.18 | $1.67 | +$0.49 (+41.5%) beat | — | +9.0% +9.2 vs SPY | +6.2% | +7.6% | |
| May 2, 2023 AMC | $1.22 | $1.51 | +$0.29 (+23.8%) beat | — | +4.7% +5.4 vs SPY | +0.8% | +0.2% | |
| Feb 2, 2023 AMC | $0.66 | $0.98 | +$0.32 (+48.5%) beat | — | +9.8% +10.8 vs SPY | +8.5% | +6.5% | |
| Nov 1, 2022 AMC | $0.78 | $0.93 | +$0.15 (+19.2%) beat | — | -6.1% -3.6 vs SPY | +1.9% | -2.5% | |
| Aug 3, 2022 AMC | $0.93 | $0.93 | $0.00 (0.0%) in line | — | -4.7% -4.6 vs SPY | -5.4% | +0.4% | |
| May 2, 2022 AMC | $0.96 | $1.31 | +$0.35 (+36.5%) beat | — | +3.0% +2.5 vs SPY | -1.0% | +9.9% | |
| Feb 3, 2022 AMC | $0.85 | $0.66 | −$0.19 (−22.4%) miss | — | -14.5% -14.9 vs SPY | -12.3% | -14.5% | |
| Nov 1, 2021 AMC | $1.02 | $1.21 | +$0.19 (+18.6%) beat | — | +1.2% +0.8 vs SPY | +2.2% | +0.5% | |
| Aug 3, 2021 BMO | $1.31 | $0.95 | −$0.36 (−27.5%) miss | — | — | — | — | |
| Apr 30, 2021 BMO | $1.46 | $1.62 | +$0.16 (+11.0%) beat | — | — | — | — | |
| Feb 4, 2021 BMO | $1.75 | $2.03 | +$0.28 (+16.0%) beat | — | — | — | — | |
| Nov 2, 2020 BMO | $2.25 | $3.22 | +$0.97 (+43.1%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | $1.09 (15) | $0.81 – $1.20 | +29% | -13.9% | ▲1 ▼10 | $1.9B | +31% |
| Next quarter · Dec 31, 2026 | $1.34 (15) | $1.21 – $1.47 | -4% | -6.1% | ▲1 ▼1 | $1.9B | +13% |
| Current year · Jun 30, 2027 | $5.78 (18) | $5.55 – $5.89 | +5% | -7.4% | ▲3 ▼13 | $7.6B | +14% |
| Next year · Jun 30, 2028 | $6.25 (17) | $5.80 – $6.57 | +8% | -7.9% | ▲0 ▼2 | $7.8B | +2% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.